Search results
Results from the WOW.Com Content Network
In October 2012, Merck & Co. announced that starting in 2014 it would move its headquarters to the Schering-Plough site (formerly belonging to Ciba, Ciba-Geigy and Novartis) in Summit, New Jersey, acquired in the November 2009 acquisition of Schering, and planned to close the Whitehouse Station headquarters building upon completion of the move ...
New Jersey has a nickname "Medicine Chest of the World" due to its large workforce in biopharmaceutical industry. As of 2019, twelve of top 20 biopharmaceutical companies in the world has U.S. headquarters in the state. [9] [10]
Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group and owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the Novartis Group. [110] Novartis's businesses are divided into two operating divisions: Innovative Medicines and Sandoz (generics). [111]
New Jersey Hospital Association 39°50′38″N 75°09′00″W / 39.844°N 75.150°W / 39.844; - This article relating to a hospital in New Jersey is a stub .
In March 2020, Merck was one of ten companies recognised at the inaugural Manufacturing Awards by New Jersey Business magazine and the New Jersey Business and Industry Association. [118] In June 2020, Merck acquired Themis Bioscience, a company focused on vaccines and immune-modulation therapies for infectious diseases including COVID-19 and ...
The Becton, Dickinson and Company Corporate Headquarters is a corporate campus in Franklin Lakes, New Jersey.Built between 1986 and 1992, the buildings serve as the corporate and divisional headquarters of the Becton, Dickinson (BD) medical technology company.
“The model that is geared toward alcoholism doesn’t effectively address heroin addiction,” Merrick said. “In a perfect world, we would have a 12-step model integrated with medically assisted therapy.” At least some of the top officials overseeing Kentucky’s response to the opioid epidemic are as open to medications as Merrick is.
The Roche Institute of Molecular Biology was created on July 14, 1967 when John Burns, then the vice president of research at Hoffman-La Roche, persuaded biochemist Sidney Udenfriend to leave the National Institutes of Health and help him create a basic science institute at the Hoffman-La Roche Nutley, New Jersey, facility. It lasted for 28 ...